Tenax Therapeutics, Inc.
TENX
$14.61
$0.775.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.91M | 6.48M | 5.67M | 5.66M | 2.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.45M | 16.81M | 11.79M | 11.34M | 7.30M |
| Operating Income | -16.45M | -16.81M | -11.79M | -11.34M | -7.30M |
| Income Before Tax | -15.54M | -15.80M | -10.85M | -10.41M | -6.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.54M | -15.80M | -10.85M | -10.41M | -6.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.54M | -15.80M | -10.85M | -10.41M | -6.27M |
| EBIT | -16.45M | -16.81M | -11.79M | -11.34M | -7.30M |
| EBITDA | -- | -- | -- | -- | -7.29M |
| EPS Basic | -0.38 | -0.40 | -0.27 | -0.28 | -0.18 |
| Normalized Basic EPS | -0.24 | -0.25 | -0.17 | -0.18 | -0.11 |
| EPS Diluted | -0.38 | -0.40 | -0.27 | -0.28 | -0.18 |
| Normalized Diluted EPS | -0.24 | -0.25 | -0.17 | -0.18 | -0.11 |
| Average Basic Shares Outstanding | 40.92M | 39.74M | 39.57M | 36.58M | 35.29M |
| Average Diluted Shares Outstanding | 40.92M | 39.74M | 39.57M | 36.58M | 35.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |